Published in Vestn Akad Med Nauk SSSR on January 01, 1968
H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers. Hum Vaccin Immunother (2015) 0.84
[Serological and epidemological data on associated vaccines against measles and mumps]. Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol (1965) 1.40
[Use of the genetic recombination method for obtaining vaccinal strains of the influenza virus]. Vopr Virusol (1977) 0.94
[Isolation of temperature-sensitive strains of the influenza virus in the epidemic caused by the A/Victoria virus in 1975-1976]. Vopr Virusol (1979) 0.91
Testing the safety and effectiveness of oral administration of a live influenza vaccine. Bull World Health Organ (1970) 0.91
[Preliminary results of the Russia (St.Petersburg)/WHO program for the evaluation of the effectiveness of breast self-examination]. Vopr Onkol (1996) 0.89
Conditions for production of thermosensitive attenuated influenza virus recombinants. Acta Virol (1978) 0.87
Peculiarities of obtaining attenuated thermosensitive recombinants of influenza A virus at the end of the H3N2 epidemic cycle. Acta Virol (1980) 0.86
Attenuated ts-recombinants of influenza A/USSR/77 (H1N1) virus obtained by crossing with the cold-adapted donor A/Leningrad/134/57 (H2N2) virus. Acta Virol (1982) 0.86
Pathogenicity of cryophilic and thermophilic strains of influenza type A2 virus for developing chick embryos and albino mice. Acta Virol (1969) 0.84
[Experience in selecting safe heat-sensitive influenza virus A recombinants]. Vopr Virusol (1979) 0.84
[The NS gene--a possible determinant of apathogenicity of a cold-adapted donor of attenuation A /Leningrad/134/47/57 and its reassortants]. Vopr Virusol (1995) 0.82
Temperature-sensitive recombinants of influenzavirus B. Acta Virol (1978) 0.79
[The reactive and immunogenic properties and epidemiological effectiveness of further attenuated influenza virus vaccinal strains (observed in preschool children)]. Vopr Virusol (1966) 0.78
[The effect of amplifying reproduction of influenza virus in mouse lungs during simultaneous infection with two cold-adapted strains]. Vopr Virusol (1990) 0.78
[Combined immunization against influenza and other viral respiratory infections]. Vestn Akad Med Nauk SSSR (1970) 0.77
[Epidemiologic effectiveness of live enteral adenovirus and influenza vaccine on susceptible groups of adults]. Vestn Akad Med Nauk SSSR (1968) 0.77
[Reactogenicity, genetic stability and effectiveness of a live recombinant influenza vaccine for children designed on the base of a cold-adapted attenuation donor A/Leningrad/134/47/57]. Vopr Virusol (1986) 0.76
[The inoculation properties of live recombinant influenza vaccine types A and B used separately and jointly in children 3 to 14]. Vopr Virusol (1992) 0.76
Interfering activity of virulent and attenuated influenza virus strains. Acta Virol (1976) 0.76
Correlation between reproductive and interfering activities of epidemic and thermosensitive influenza virus strains. Acta Virol (1982) 0.75
Effectiveness of peroral and intranasal immunization of school children with live allantoic influenza vaccine- and comparative study. J Hyg Epidemiol Microbiol Immunol (1979) 0.75
[Correlations between thermosensitivity and interference activity of the influenza virus]. Virologie (1981) 0.75
[Differentiating markers of virulent and attenuated (cold-adapted) strains of influenza A virus]. Vopr Virusol (1977) 0.75
[Variations in the temperature range for reproduction of virulent and attenuated cold-adapted influenza A viruses]. Vopr Virusol (1989) 0.75
[Prevention of influenza in children]. Med Sestra (1968) 0.75
[Growth characteristics of single gene mutants of A/Leningrad/134/57(H2N2) influenza virus and cold-adapted mutant A/Leningrad/134/17/57(H2N2)]. Vopr Virusol (2007) 0.75
[Several characteristics of therapy of influenza in children]. Sov Med (1967) 0.75
[Comprehensive prophylactic examinations of women for the detection of early forms of breast cancer]. Vopr Onkol (1978) 0.75
[A study of epidemics caused by respiratory syncytial virus in young children]. Vopr Okhr Materin Det (1969) 0.75
Study of the avidity of anti-influenza antibodies in sera of convalescents or subjects vaccinated with a live influenza virus vaccine. Acta Virol (1969) 0.75
[Live influenza vaccine in the USSR: its development, study and practical use]. Zh Mikrobiol Epidemiol Immunobiol (1986) 0.75
[ts-Mutations in the genomes of cold-adapted variants of influenza A/Hong Kong/1/68(H3N2) and A/Victoria/35/72(H3N2) viruses]. Genetika (1993) 0.75
[A study of respiratory syncitial infection in young children]. Vopr Okhr Materin Det (1967) 0.75
Results of study of live antiparotitic vaccine and perspectives for the elimination of mumps as a mass infection. J Hyg Epidemiol Microbiol Immunol (1967) 0.75
[The ts phenotype of reisolates from children inoculated with live cold-adapted influenza vaccine type A]. Vopr Virusol (1990) 0.75
[Attenuated recombinant influenza type B virus obtained during crossing of virus B/Ann Arbor/2/86 with the cold-adapted strain B/Leningrad/14/17/55]. Vopr Virusol (1990) 0.75
[Study of the harmlessness, antigenicity and immunogenic activity of live antiparainfluenza vaccine]. Vestn Akad Med Nauk SSSR (1970) 0.75
[Comparative characteristics of reactogenic and immunogenic properties of the attenuated live influenza vaccine in intranasal and peroral administration in children]. Pediatriia (1969) 0.75
[Present status of the problem of vaccinoprophylaxis against influenza and acute respiratory diseases]. Vestn Akad Med Nauk SSSR (1975) 0.75
[Results of controlled observation of the selection of vaccine strains of influenza virus]. Vopr Virusol (1969) 0.75
[Results and prospects for vaccinal prevention of influenza]. Vopr Virusol (1977) 0.75
[Molecular genetic analysis of a cold-adapted donor attenuation strain for a pediatric liver influenza vaccine, of recombinants based on it and of isolates from vaccinated children]. Vopr Virusol (1984) 0.75
Partial change of the ts-phenotype of cold-adapted influenza virus strain grown in canine kidney cells in the presence of trypsin. Acta Virol (1982) 0.75
[The immunogenic properties and prophylactic efficacy of a live polyvalent influenza vaccine in children 5 to 14 years old]. Vopr Virusol (1994) 0.75
Analysis of antigenic and biological properties of influenza B virus strains, isolated in Leningrad in 1955-1967. Acta Virol (1971) 0.75
Search for optimal scheme for administering live allantoic influenza vaccine. J Hyg Epidemiol Microbiol Immunol (1983) 0.75
[Basis of the anthroponotic nature of human pandemic influenza A viruses]. Vopr Virusol (1981) 0.75
[Ways of further reduction of the incidence of tuberculosis among adolescents]. Probl Tuberk (1977) 0.75
Data on safety and epidemiological efficiency of antiinfluenza vaccine studied on pre-school children. J Hyg Epidemiol Microbiol Immunol (1967) 0.75
[The evaluation of the degree of attenuation of cold-adapted influenza A virus strains in CBA-strain mouse and Syrian hamster models]. Vopr Virusol (1992) 0.75
[Evaluation of the preventive activity of the new anti-influenza drug, amantadine]. Vrach Delo (1969) 0.75
[Use of adriamycin in the treatment of metastatic breast cancer]. Vopr Onkol (1984) 0.75
[Proportion and intensity parameters of the incidence of acute respiratory infections during influenza epidemic and interepidemic periods]. Zh Mikrobiol Epidemiol Immunobiol (1975) 0.75
[Genetic and phenotypic analysis of heterogeneous population of a cold-adapted donor of the A/Leningrad/134/17/57 (H2N2) attenuation and of the donor-based reassortant influenza vaccine strains]. Vopr Virusol (2005) 0.75
[Epidemiological characteristics of mumps in children's collectives after mass vaccination]. Zh Mikrobiol Epidemiol Immunobiol (1965) 0.75
[The selection of cold-adapted variants of the influenza viruses H1N1 and H3N2 and their antigenic and genetic characteristics]. Vopr Virusol (1991) 0.75
[Interference and its overcoming during the reproduction of 2 influenza A virus strains in an experiment]. Vopr Virusol (1993) 0.75
Basic principles and stages in testing new vaccines against respiratory viruses. Am Rev Respir Dis (1976) 0.75
[Lymphangiosarcoma of the upper extremity after mastectomy for cancer]. Vestn Khir Im I I Grek (1981) 0.75
[Genetic basis for construction of the life influenza type A vaccine using temperature-sensitive mutants]. Mol Gen Mikrobiol Virusol (1990) 0.75
[Use of "split" courses of combination chemotherapy in breast cancer]. Vopr Onkol (1981) 0.75
[Immunogenicity of attenuated reassortants of influenza A virus /Leningrad/134/47/57 (H2N2) for mice, depending on their genome]. Vopr Virusol (1995) 0.75
[Antitumor activity of cold-adapted strains of influenza virus in a model transformed murine tumor cells]. Vopr Virusol (1999) 0.75
Interfering activity of epidemic, attenuated and recombinant strains of influenza A virus. Acta Virol (1986) 0.75
[The temperature sensitivity of epidemic influenza A viruses as a marker of immunogenicity of reassortant vaccinal strains]. Vopr Virusol (2003) 0.75
[Cold-adapted strain of A/Leningrad/134/47/57 (H2N2)--a special attenuation donor of live influenza vaccine for children and the isolation of its recombinants]. Vopr Virusol (1984) 0.75
[Results of mass immunization against mumps]. Vopr Virusol (1966) 0.75
[Mutations in the genes coding for hemagglutinin and neuraminidase in cold-adapted variants of the influenza virus A/Leningrad/134/57 (H2N2)]. Vopr Virusol (1991) 0.75
[Criteria of primary screening of attenuated strains for live vaccine against Influenza A]. Vopr Virusol (2001) 0.75
[Estimation of economic losses due to influenza incidence and acute respiratory diseases in children]. Pediatriia (1977) 0.75
Experimental basis of enhancing the immunogenicity of influenza B virus by genetic recombination. Acta Virol (1980) 0.75